Atrial fibrillation (AFib) is a kind of irregular heartbeat, or arrhythmia. A problem with the electrical signals that control your heart’s pumping action causes it to beat too fast in a pattern that ...

Direct current cardioversion for symptomatic atrial fibrillation or flutter is feasible and safe in patients implanted with the Watchman left atrial appendage (LAA) occlusion device, even in the ...

A cardioversion procedure can reset your heart to its normal rhythm. There are two types: Electrical cardioversion. Your doctor gives your heart an electrical shock through paddles or patches on your ...

Patients with recent-onset atrial fibrillation commonly undergo immediate restoration of sinus rhythm by pharmacologic or electrical cardioversion. However, whether immediate restoration of sinus ...

Cardiologists at University of Utah Health use this therapy for people with heart rhythm disorders (arrhythmias), including atrial flutter and atrial fibrillation (AFib). Your heart’s electrical ...

Electrical cardioversion without routine extra anticoagulation around the procedure may be feasible for people who've already received left atrial appendage (LAA) occlusion, according to a small ...

PARIS — Cardioversion with maximum-fixed energy shocks was more effective than low-escalating energy shocks for the treatment of patients with atrial fibrillation, according to a late-breaking science ...

TURKU, FINLAND — Even if electrical cardioversion of atrial fibrillation (AF) is carried out without anticoagulation within 48 hours of acute-AF onset, the first 12 hours of that period provide by far ...

Cardioversion is a medical procedure to correct a heartbeat that is irregular or too fast. It can involve risks and side effects but is generally safe and effective. Doctors primarily use ...

Nicholas P. Gall, M.Sc., M.D., M.R.C.P.; Francis D. Murgatroyd, M.A., F.R.C.P., F.A.C.C. From these and subsequent studies, it became clear that cardioversion was ...

The drug-shock strategy was more effective for patients experiencing atrial fibrillation for the first time and for patients younger than 70 years, the researchers said. Both the anti-arrhythmia drug ...

Early stroke and systemic embolism rates in patients following cardioversion for atrial fibrillation (A-fib) are low and comparable between those receiving warfarin or the novel oral anticoagulant ...